Lung cancer

Patients with chronic obstructive pulmonary disease are at increased risk for both the development of primary lung cancer, as well as poor outcome after lung cancer diagnosis and treatment. Because of existing impairments in lung function, patients with COPD often do not meet traditional criteria for tolerance of definitive surgical lung cancer therapy. Emerging information with respect to the pathophysiology of COPD in lung resection demonstrates that postoperative decrements in lung capacity may be less than anticipated by traditional prediction tools. In patients with COPD, more inclusive consideration for surgical resection with curative intent might be appropriate as constrained surgical resections or nonsurgical therapeutic options provide inferior survival. Besides, optimizing perioperative COPD therapeutic care as indicated by clinical practice rules including smoking cessation can possibly minimize morbidity and enhance functional status in this often severely impaired patient population. Lung Conferences concentrates on the risk factor for development of lung cancer.

  • Small-Cell Lung Carcinoma
  • Prognosis of Lung Cancer
  • Genetic susceptibility
  • Chronic inflammation

Related Conference of Lung cancer

August 29-30, 2022

10th Annual Congress on Pulmonary and Critical Care

Amsterdam, Netherlands
August 29-30, 2022

12th International Conference on COPD and Lungs

Amsterdam, Netherlands
September 22-23, 2022

3rd International Conference on Lung Diseases

Amsterdam, Netherlands
November 07-08, 2022

13th International Conference on Pulmonary & Respiratory Medicine

Singapore City, Singapore
November 10-11, 2022

3rd International Conference on Hepatitis

Madrid, Spain
November 24-25, 2022

34th Global Summit Pulmonary Diseases & Treatment

Amsterdam, Netherlands

Lung cancer Conference Speakers

Recommended Sessions

Related Journals

Are you interested in